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Letters to the Editor / Journal of Cardiology 65 (2015) 439–440440thors’ reply
We appreciate Dr Sertoglu and colleagues’ interest in reviewing
r published article [1]. Here we propose clariﬁcations on the
entioned points.
First, we absolutely admit that assessing serum folate, vitamin
2, and methylmalonic acid (MMA) is beneﬁcial in differentiating
e underlying cause of hyper-homocysteinemia (HHcy). However,
ey have limited applicability, especially in a developing clinical
tting such as Iran. Even if readily accessible, we believe that
rther studies and additional evidence should support the utility
traditional risk factors is derived from risk reclassiﬁcation, rather
than mean/median comparisons.
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